Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth

Nucleic Acids Research

Volumn 37, Issue 14, 2009, Pages 4559-4569

  Crombez, Laurence ^a   Morris, May Catherine ^a   Dufort, Sandrine ^b,c   Aldrian Herrada, Gudrun ^a   Nguyen, Quan ^d   Mc Master, Gary ^d   Coll, Jean Luc ^b,c   Heitz, Frederic ^a   Divita, Gilles ^a  

^a Centre National de la Recherche Scientifique   (France)

^b INSTITUT ALBERT BONNIOT   (France)

^c UNIV GRENOBLE ALPES   (France)

^d Panomics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CARRIER PROTEIN; CHOLESTEROL FUNCTIONALIZED PEPTIDE MPG8; CYCLIN B; CYCLIN DEPENDENT KINASE 1; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; NAKED SMALL INTERFERING RNA; NANOPARTICLE; PEPTIDE MPG8; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY TEST; DOWN REGULATION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG HALF LIFE; DRUG POTENCY; DRUG STABILITY; DRUG TISSUE LEVEL; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; LUNG CANCER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN TARGETING;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN B; FEMALE; G2 PHASE; HUMANS; INJECTIONS; MICE; MICE, NUDE; NANOPARTICLES; NEOPLASMS; OLIGOPEPTIDES; PEPTIDES; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS;

EID: 68149125757     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp451     Document Type: Article

References (37)

1. Elbashir,S.M., Harborth,J., Lendeckel,W., Yalcin,A., Weber,K. and Tuschl,T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cell. Nature, 411, 494-498.
2. Dorsett,Y. and Tuschl,T. (2004) siRNAs: Applications in functional genomics and potential as therapeutics. Nat. Rev. Drug Discov., 3, 318-329.
3. Dykxhoorn,DM., Palliser,D. and Lieberman,J. (2006) The silent treatment: siRNAs as small molecule drugs. Gene Ther., 13, 541-552.
4. De Fougerolles,A., Vornlocher,H-P., Maraganore,J. and Lieberman,J. (2007) Interfering with disease: A progress report on siRNA-based therapeutics. Nat. Rev. Drug Disc., 6, 443-453.
5. Akhtar,S. and Benter,I.F. (2007) Nonviral delivery of synthetic siRNA in vivo. J. Clinical Invest., 117, 3623-3632.
6. El-Andaloussi,S., Holm,T. and Langel,Ü. (2005) Cell-penetrating peptides:mEchanism and applications. Cur. Pharma. Design., 11 3597-3611.
7. Deshayes,D., Morris,MC., Divita,G. and Heitz,F. (2005) Cell-penetrating peptides: Tools for intracellular delivery of therapeutics. Cell. Mol. Life Sci., 16, 1839-1849.
8. Meade,B.R. and Dowdy,S.F. (2007) Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides. Adv. Drug Deliv. Rev. 59, 134-140.
9. Morris,M.C., Deshayes,S., Heitz,F. and Divita,G. (2008) Cell-penetrating peptides: From molecular mechanisms to therapeutics. Biol. Cell., 100, 201-217.
10. Simeoni,F., Morris,M.C., Heitz,F. and Divita,G. (2003) Insight into the mechanism of the peptide-based gene delivery system MPG: Implications for delivery of siRNA into mammalian cells. Nucleic Acids Res., 31, 2717-2724.
11. Morris,K.V., Chan,S.W., Jacobsen,S.E. and Looney,D.J. (2004) Small interfering RNA-induced transcriptional gene silencing in human cells. Science, 305, 1289-1292.
12. Kumar,P., Wu,H., McBride,J.L., Jung,K.E., Kim,M.H., Davidson,B.L., Lee,S.K., Shankar,P. and Manjunath,N. (2007) Transvascular delivery of small interfering RNA to the central nervous system. Nature, 7149, 39-43.
13. Kim,W.J., Christensen,L.V., Jo,S., Yockman,J.W., Jeong,J.H., Kim,Y.H. and Kim,S.W. (2006) Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma. Mol. Ther., 14, 343-350.
14. Lundberg,P., El-Andaloussi,S., Sütlü,T., Johansson,H. and Langel,U. (2007) Delivery of short interfering RNA using endosomolytic cell-penetrating peptides. FASEB J., 11, 2664-2671.
15. Veldhoen,S., Laufer,S.D., Trampe,A. and Restle,T. (2006) Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: Quantitative analysis of uptake and biological effect. Nucleic Acids Res., 34, 6561-6573.
16. Crombez,L., Aldrian-Herrada,G., Konate,K., Nguyen,Q.N., Mc Master,G.K., Brasseur,R., Heitz,F. and Divita,G. (2009) A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells. Mol. Ther., 17, 95-103.
17. Kumar,P., Ban,H.S., Kim,S.S., Wu,H., Pearson,T., Greiner,D., Laouar,A., Yao,J., Lee,S.K. and Shankar,P. (2008) T-Cell specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell, 134, 577-586.
18. Morris,M.C., Depollier,J., Mery,J., Heitz,F. and Divita,G. (2001) A peptide carrier for the delivery of biologically active proteins into mammalian cells,. Nat. Biotechnol., 19, 1173-1176.
19. Crombez,L., Morris,M.C., Deshayes,S., Heitz,F. and Divita,G. (2008) Peptide-based nanoparticle for ex vivo and in vivo drug delivery. Curr. Pharm. Des., 14, 3656-3665.
20. Zeineddine,D., Papadimou,E., Chebli,K., Gineste,M., Liu,J., Gr,C., Thurig,S., Behfar,A., Wallace,V.A., Skerjanc,I.S. et al. (2006) Oct-3/4 dose dependently regulates specification of embryonic stem cells toward a cardiac lineage and early heart development. Dev. Cell, 11, 535-546.
21. Morgan,D.O. (1997) Cyclin-dependent kinases: Engines, clocks, and microprocessors,. Annu. Rev. Cell Dev. Biol., 13, 261-291.
22. Goga,A., Yang,D., Tward,A.D., Morgan,D.O. and Bishop,J.M. (2007) Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC. Nat. Med., 13, 820-827.
23. Yuan,J., Krämer,A., Matthess,Y., Yan,R., Spänkuch,B., Gätje,R., Knecht,R., Kaufmann,M. and Strebhardt,K. (2006) Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivo. Oncogene, 25, 1753-1762.
24. Morris,M.C., Gros,E., Aldrian-Herrada,G., Choob,M., Archdeacon,J., Heitz,F. and Divita,G. (2007) A non-covalent peptide-based carrier for in vivo delivery of DNA mimics. Nucleic Acids Res., 35, e49.
25. Morris,M.C., Vidal,P., Chaloin,L., Heitz,F. and Divita,G. (1997) A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res., 25, 2730-2736.
26. Josserand,V., Texier-Nogues,I., Huber,P., Favrot,M.C. and Coll,J.L. (2007) Non-invasive in vivo optical imaging of the lacZ and luc gene expression in mice. Gene Ther., 14, 1587-1593.
27. Jin,Z.H., Josserand,V., Foillard,S., Boturyn,D., Dumy,P., Favrot,M.C. and Coll,J.L. (2007) In vivo optical imaging of integrin alphaV-beta3 in mice using multivalent or monovalent cRGD targeting vectors. Mol. Cancer, 6, 41.
28. Crombez,L., Charnet,A., Morris,M.C., Aldrian-Herrada,G., Heitz,F. and Divita.,G. (2007) A non-covalent peptide-based strategy for siRNA delivery. Biochem. Soc. Trans., 35, 44-46.
29. Spänkuch,B., Hurunci-Csacsko,E., Kaufmann,M. and Strebhardt,K. (2007) Rational combinations of siRNA targeting Plk1 with breast cancer drugs. Oncogene, 26, 5793-5807.
30. Wolfrum,C., Shi,S., Jayaprakash,K.N., Jayaraman,M., Wang,G., Pandey,R., Rajeev,K.G., Nakayama,T., Charrise,K., Ndungo,E.M. et al. (2007) Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nat. Biotechnol., 25, 1149-1157.
31. Soutschek,J., Akinc,A., Bramlage,B., Charisse,K., Constien,R., Donoghue,M., Elbashir,S., Geick,A., Hadwiger,P., Harborth,J. et al. (2004) Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature, 432, 173-178.
32. Judge,A.D., Sood,V., Shaw,J.R., Fang,D., McClintock,K. and MacLachlan,I. (2005) Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat. Biotechnol., 23, 457-466.
33. Sioud,M. (2006) Innate sensing of self and non-self RNAs by Toll-like receptors. Trends Mol. Med., 12, 167-176.
34. Moschos,S.A., Jones,S.W., Perry,M.M., Williams,A.E., Erjefalt,J.S., Turner,J.J., Barnes,P.J., Sproat,B.S., Gait,M.J. and Lindsay,M.A. (2007) Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity. Bioconjug. Chem., 18, 1450-1459.
35. Zimmermann,T.S., Lee,A.C., Akinc,A., Bramlage,B., Bumcrot,D., Fedoruk,M.N., Harborth,J., Heyes,J.A., Jeffs,L.B., John,M. et al. (2006) RNAi-mediated gene silencing in non-human primates. Nature, 441, 111-114.
36. Song,E., Zhu,P., Lee,S.K., Chowdhury,D., Kussman,S., Dykxhoorn,D.M., Feng,Y., Palliser,D., Weiner,D.B., Shankar,P. et al. (2005) Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat. Biotechnol., 23, 709-717.
37. Fountaine,T.M., Wood,M.J. and Wade-Martins,R. (2005) Delivering RNA interference to the mammalian brain. Curr. Gene Ther., 5, 399-410.